• Category: Pharma
  • Investment Status: IPO
  • Medical Field: Dermatology
  • Medical Center: Soroka Medical Center
  • Inventors: Prof. Lior Rosenberg


MediWound Ltd. is a biotechnology niche specialty company focused on developing, manufacturing and globally commercializing innovative products that address unmet needs in the fields of severe burn and chronic wound management.

MediWound’s goal is to provide healthcare professionals and patients with its innovative, burn wound eschar removal agent, NexoBrid and wound treatment technology PolyHeal™, both approved in the European market as well as additional markets.